Anti-thymocyte-globulin as part of the preparative regimen prevents graft failure and severe graft versus host disease (GvHD) in allogeneic stem cell transplantation from unrelated donors

Annals of Hematology

Volumn 80, Issue 4, 2001, Pages 209-215

  Kröger, Nicolaus ^a   Zabelina, Tatjana ^c   Krüger, William ^a   Renges, Helmut ^a   Stute, Norbert ^a   Dürken, Matthias ^a   Graf Von Finkenstein, Friedrich ^a   Erttmann, Rolf ^a   Kabisch, Hartmut ^a   Schafhausen, Philipe ^a   Jaburg, Nicole ^a   Löliger, Cornelius ^b   Zander, Axel R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c Pavlow University   (Russian Federation)

Author keywords

Anti thymocyte globulin; Graft versus Host disease; Unrelated bone marrow transplantation

Indexed keywords

ACICLOVIR; AMPHOTERICIN; BUSULFAN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; FLUCONAZOLE; FLUDARABINE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN G; MELPHALAN; METHOTREXATE; METRONIDAZOLE; OFLOXACIN; PENTAMIDINE; PROSTAGLANDIN E1; PROSTAVASIN; STEROID; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE DISEASE; ADOLESCENT; ADULT; ALLOGRAFT; ANAPHYLACTIC SHOCK; ARTICLE; BLAST CELL CRISIS; BRONCHOSPASM; CHILD; CHILL; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DONOR; FEMALE; FEVER; FLUSHING; FOLLOW UP; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES VIRUS INFECTION; HLA SYSTEM; HUMAN; HYPERTENSION; INCIDENCE; INFECTION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PNEUMOCYSTOSIS; PRIORITY JOURNAL; RELAPSE; SERUM SICKNESS; STORAGE DISEASE; SURVIVAL; TACHYCARDIA; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; RECURRENCE; REOPERATION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0035010454     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770000269     Document Type: Article

References (26)

1. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: Increased risk of relapse associated with T-cell depletion
2. Bone marrow transplantation for acute leukemia
3. State of art review. Bone marrow transplantation treatment for storage diseases
4. Marrow transplantation from related donors other than HLA-identical siblings
5. Effect of HLA incompatibility on graft versus host disease, relapse, and survival after marrow transplantation for patients with leukemia and lymphoma
6. Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program
7. Unrelated donor marrow transplantation for chronic myelogenous leukemia: Initial experience of the National Marrow Donor Program
8. The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft versus host disease prophylaxis regimen of and prednisone
9. Cyclosphosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia
10. Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: Preliminary results
11. 1994 Consensus Conference on acute GvHD-grading
12. Results for allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings
13. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia
14. Bone marrow transplantation for patients with chronic myeloid leukemia
15. Successful allogeneic transplantation of T-cell depleted bone marrow from closely HLA-matched unrelated donors
16. Pretransplant serotherapy reduces GvHD without increasing relapse after unrelated donor (UD) BMT
17. Monitoring anti-thymocyte globulin (ATG) in bone marrow recipients
18. Conditioning treatment with Antithymocyte Globulin (ATG) modifies Graft-vs-Host Disease in recipients of marrow from unrelated donors
19. Allogeneic transplantation from unrelated donors: Improved outcome using in vivo T-cell depletion
20. Anti Human T-lymphocyte globulin (ATG) as part of conditioning regimen in unrelated bone marrow transplantation of patients with CML in chronic or accelerated phase
21. Use of a five-agent GvHD prevention regimen in recipients of unrelated donor marrow
22. ATG Serotherapy during pretransplant conditioning in unrelated donor BMT: Dose dependent modulation of GvHD
23. Schwerdtfeger Potent effect of ATG as part of the conditioning in matched unrelated donor (MUD) transplantation
24. Prevention of GvHD with broad spectrum anti-T-lymphocyte globulin
25. Effect on cytokine release, engraftment and GvHD of different anti T-cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation